Genetic polymorphisms of bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese patients with Crigler-Najjar syndrome or Gilbert's syndrome as well as in healthy Japanese subjects.

scientific article

Genetic polymorphisms of bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese patients with Crigler-Najjar syndrome or Gilbert's syndrome as well as in healthy Japanese subjects. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1440-1746.2004.03370.X
P698PubMed publication ID15304120

P2093author name stringHiroshi Sato
Jun Araki
Makoto Kuroda
Keisuke Takeuchi
Tomoaki Ishihara
Yoshinao Kobayashi
Yukihiko Adachi
Yoshihiro Maruo
Shigenori Tamaki
Masahiko Kaito
Rumi Mifuji
Toshio Itani
P2860cites workRacial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?Q24670527
Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotypeQ28140057
Inherited disorders of bilirubin metabolismQ28217356
Identification of an A-to-G missense mutation in exon 2 of the UGT1 gene complex that causes Crigler-Najjar syndrome type 2Q28258092
Identification of defect in the genes for bilirubin UDP-glucuronosyl-transferase in a patient with Crigler-Najjar syndrome type IIQ28258225
Molecular genetic basis of Gilbert's syndromeQ33756586
The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndromeQ34057969
Genetic variation in bilirubin UPD-glucuronosyltransferase gene promoter and Gilbert's syndromeQ34374626
Altered coding for a strictly conserved di-glycine in the major bilirubin UDP-glucuronosyltransferase of a Crigler-Najjar type I patientQ36715577
P433issue9
P921main subjectCrigler-Najjar syndromeQ1140000
P304page(s)1023-1028
P577publication date2004-09-01
P1433published inJournal of Gastroenterology and HepatologyQ15764401
P1476titleGenetic polymorphisms of bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese patients with Crigler-Najjar syndrome or Gilbert's syndrome as well as in healthy Japanese subjects.
P478volume19

Reverse relations

cites work (P2860)
Q44767175A genome-wide search for non-UGT1A1 markers associated with unconjugated bilirubin level reveals significant association with a polymorphic marker near a gene of the nucleoporin family
Q33283468Adaptive evolution of multiple-variable exons and structural diversity of drug-metabolizing enzymes
Q92999855Analysis of the UGT1A1 Genotype in Hyperbilirubinemia Patients: Differences in Allele Frequency and Distribution
Q35807302Association of Neonatal Hyperbilirubinemia with UGT1A1 Gene Polymorphisms: A Meta-Analysis.
Q34257505Bilirubin Glucuronidation Revisited: Proper Assay Conditions to Estimate Enzyme Kinetics with Recombinant UGT1A1
Q51731636Bilirubin concentrations in thalassemia heterozygotes in university students.
Q40468832Changes in the liver function tests during the attacks of familial Mediterranean fever.
Q46825406Comparative genomics analysis of human sequence variation in the UGT1A gene cluster
Q38885161Contribution of G71R mutation to Gilbert's syndrome phenotype in a Greek patient: A case report
Q54571855Crigler-Najjar syndrome type 2.
Q51766831Effect of common exon variant (p.P364L) on drug glucuronidation by the human UDP-glucuronosyltransferase 1 family.
Q49593574Effects of Gly71Arg mutation in UGT1A1 gene on neonatal hyperbilirubinemia: a systematic review and meta-analysis.
Q37876401Ethnic differences in the metabolism, toxicology and efficacy of three anticancer drugs
Q92140102Genetic Spectrum of UGT1A1 in Korean Patients with Unconjugated Hyperbilirubinemia
Q37775981Genetic polymorphism in metabolism and host defense enzymes: implications for human health risk assessment
Q53572392Gilbert's syndrome phenotypically expressed as Crigler-Najjar syndrome type II.
Q33867195Gilbert's syndrome: High frequency of the (TA)7 TAA allele in India and its interaction with a novel CAT insertion in promoter of the gene for bilirubin UDP-glucuronosyltransferase 1 gene
Q43963256Hyperbilirubinemia in pazopanib- or sunitinib-treated patients in COMPARZ is associated with UGT1A1 polymorphisms.
Q35881663Identification of Promotor and Exonic Variations, and Functional Characterization of a Splice Site Mutation in Indian Patients with Unconjugated Hyperbilirubinemia.
Q34159702Incidence of atazanavir-associated hyperbilirubinemia in Korean HIV patients: 30 months follow-up results in a population with low UDP-glucuronosyltransferase1A1*28 allele frequency
Q57453351Influence of UGT1A1 polymorphism on etoposide plus platinum-induced neutropenia in Japanese patients with small-cell lung cancer
Q37709064Molecular Analysis of the UGT1A1 Gene in Korean Patients with Crigler-Najjar Syndrome Type II.
Q64281770Molecular diagnosis of hereditary spherocytosis by multi-gene target sequencing in Korea: matching with osmotic fragility test and presence of spherocyte
Q37613514Mutation Analysis in Crigler-Najjar Syndrome Type II-Case Report and Literature Review.
Q26863145New insights in bilirubin metabolism and their clinical implications
Q44606105Newborn infant with prolonged jaundice
Q37173199Pharmacogenetic testing for uridine diphosphate glucuronosyltransferase 1A1 polymorphisms: are we there yet?
Q34391234Pharmacogenetics of irinotecan: An ethnicity-based prediction of irinotecan adverse events
Q28547377Spectrum of UGT1A1 Variations in Chinese Patients with Crigler-Najjar Syndrome Type II
Q38354009Systematic screening for polymorphisms within the UGT1A6 gene in three Chinese populations and function prediction through structural modeling.
Q36475104The clinical application of UGT1A1 pharmacogenetic testing: gene-environment interactions
Q43195349Treatment of childhood sarcoma with irinotecan: bilirubin level as a predictor of gastrointestinal toxicity
Q60961698UGT1A1 genotypes and unconjugated hyperbilirubinemia phenotypes in post-neonatal Chinese children: A retrospective analysis and quantitative correlation
Q40426198UGT1A1*28 polymorphism predicts irinotecan-induced severe toxicities without affecting treatment outcome and survival in patients with metastatic colorectal carcinoma

Search more.